Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Data: Ethereum's on-chain yield in Q2 drops to 2.68%, down 61% year-on-year

Data: Ethereum's on-chain yield in Q2 drops to 2.68%, down 61% year-on-year

ChaincatcherChaincatcher2026/07/03 15:37
Show original

According to ChainCatcher, citing The DeFi Report's Ethereum Q2 Ecosystem Performance Report, Ethereum's real economic value (REV) in Q2 was 88.4 million US dollars, up 7% quarter-over-quarter, but down 68% year-over-year.

The report shows that the average real on-chain yield in Q2 was only 0.17%, a decrease of 14% quarter-over-quarter and 61% year-over-year; the total on-chain yield (including issuance) was 2.68%, with the issuance portion accounting for 94%, and priority fees and MEV contributing only 0.17%. L1 GDP, DeFi activity, and L2 participation all continued to decline significantly.

The report notes that although user experience and throughput have improved, L1's fee capture capability remains weak. In the future, real-world assets and other practical applications will be needed as settlement layers to smooth cyclical fluctuations.

News Image 0
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Goldman Sachs interprets Meta (META.US) AI paradigm shift; MuseAI ushers in a new era of intelligent agents

Recently, Meta launched its personal AI agent product, Muse AI, marking the transition of consumer artificial intelligence from Q&A-based chatbots to an era of intelligent agents capable of independently completing real-world tasks. Goldman Sachs released a research report maintaining a “Buy” rating on Meta.

智通财经2026/09/14 07:16
Goldman Sachs interprets Meta (META.US) AI paradigm shift; MuseAI ushers in a new era of intelligent agents